XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Activity

25 hedge funds and large institutions have $46.5M invested in Xenon Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
–
Holders Change %
0%
% of All Funds
0.66%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
3
Increased
7
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
OM
1
Opaleye Management
Massachusetts
$2.41M
2
BI
2
BVF Inc
California
$9.05M
3
DCM
3
DAFNA Capital Management
California
$786K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$314K
5
UBS Group
5
UBS Group
Switzerland
$21K

Top Sellers

1
GCP
1
GSA Capital Partners
United Kingdom
$304K
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$0
3
IPC
3
Invesco Private Capital
New York
$3.51M
4
Deutsche Bank
4
Deutsche Bank
Germany
$61K
5
Bank of America
5
Bank of America
North Carolina
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
– -$86K -10,474 Closed
Bank of America
27
Bank of America
North Carolina
– -$18K -2,182 Closed
CSS
28
Cubist Systematic Strategies
Connecticut
– -$12K -1,440 Closed
1
2